| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |